Reimplantation of EndoBarrier device proves safe in obesity trial

04/30/2012 | (Boston)

GI Dynamics' EndoBarrier gastrointestinal sleeve can be reimplanted in obese patients who have previously been treated with the device without complications, according to a 19-patient study. The findings were presented at the 5th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders in Barcelona, Spain.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI